Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride 45802-0147
Generic: Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride
Product NDC
45802-0147- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- March 31, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA210719
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cetirizine Hydrochloride | 5 mg/1 |
| Pseudoephedrine Hydrochloride | 120 mg/1 |
Drug Class
Adrenergic alpha-Agonists [MoA]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Packaging Options(2)
12 BLISTER PACK in 1 CARTON (45802-147-53) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
24 BLISTER PACK in 1 CARTON (45802-147-62) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
External Resources